Oncobiomed

ONCOBIOMED METRICS Oncobiomed (OBM) has developed two immunotherapy technologies against cancer: TAPCells™ technology applied to more than 300 patients with highly successful results. Lycellvax generic vaccine with a centralized manufacturing model and simple production. TAPCells™ and Lycellvax. These biological vaccines stimulate and activate patient’s immune system, generating a specific response against melanoma tumors, prostate cancer,…